Healios K.K. (TYO:4593)
Japan · Delayed Price · Currency is JPY 270.00
+2.00 (0.75%)
Oct 26, 2026, 3:30 PM JST
Healios K.K. Market Cap
Healios K.K. has a market cap or net worth of 36.6 billion as of October 26, 2026. It is the 19,792nd most valuable company in the world and the 1,559th biggest in Japan. Its market cap has decreased by 35.02% in one year.
Market Cap
36.60B
Enterprise Value
30.12B
Revenue
59.00M
Global Rank
Country Rank
#1,559 Japan
PE Ratio
n/a
ChartMarket Cap Chart
Since June 16, 2015, Healios K.K.'s market cap has decreased from 67.08B to 36.60B, a decrease of -45.44%. That is a compound annual growth rate of -5.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 26, 2026 | 36.60B | 15.69% |
| Dec 30, 2025 | 31.63B | 98.29% |
| Dec 30, 2024 | 15.95B | 29.70% |
| Dec 29, 2023 | 12.30B | -25.62% |
| Dec 30, 2022 | 16.54B | -76.63% |
| Dec 30, 2021 | 70.75B | -30.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SanBio Company | 72.13B |
| Heartseed | 61.31B |
| Cuorips | 57.37B |
| 3-D Matrix | 46.46B |
| Japan Tissue Engineering | 29.73B |
| Innovacell | 21.13B |
| RaQualia Pharma | 16.22B |
| Stella Pharma | 14.67B |